BioSpace News Archive

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) today announced the appointment of former U.S. congressman Stephen Buyer to the Company’s Board of Directors

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease (SCD) treatment, today reported preliminary gross sales results of $7.0 million for the third quarter ended September 30, 2019 compared to $6.2 million for the second quarter ended June 30, 2019 based on total boxes shipped.

H. Lundbeck A/S (Lundbeck) and Alder BioPharmaceuticals (NASDAQ: ALDR) (Alder) each filed updated tender offer materials with the U.S. Securities and Exchange Commission (SEC) in connection with Lundbeck’s pending tender offer (the Offer)

Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by genomics, today announced that the Company’s TruGraf ® Blood Gene Expression Test qualifies for Medicare coverage effective November 25, 2019.

Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will release third-quarter 2019 results on Wednesday, October 30th, 2019, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Moore Fight Moore Strong (MFMS) – an organization with a mission to carry on the legacy of their best friend, Jessica Moore, to raise awareness for Metastatic Breast Cancer (MBC) – has worked to unite over 80 locations across the globe to illuminate major landmarks in green, pink and teal to raise awareness for Metastatic Breast Cancer on and around MBC Awareness Day on Sunday, October 13th

Who are Americans more likely to take health advice from…their doctors or an Instagram influencer? Would U.S. adults rather talk or text? Socialize in real life or scroll through social media?

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its third quarter ended September 30, 2019 after the market closes on Thursday, October 24, 2019.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2019 fourth quarter and fiscal year 2019 results on Tuesday, October 15, 2019, at 4:30 PM E.T.

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the National Institute for Health and Care Excellence (NICE) has recommended that women with relapsed ovarian cancer in England have access to rucaparib through the Cancer Drugs Fund (CDF)